Skip Navigation
NIH logowww.cancer.gov
Whats New logo
NCI Cancer Models Database
A database of mouse, rat, and other animal models of human cancers submitted by cancer...

eMICE Web Site – Electronic Models Information, Communication, and Education
An Internet resource providing extensive information about experimental and spontaneous animal models for cancer research,...

Biological Resources Branch (BRB) Preclinical Repository
Provides: Human cytokines (interleukin-1, interleukin-2, basic fibroblast growth factor, vascular...

»» More "What's New?" items

Resource Details

Resource Name/Title

Acquisition of Compounds and Combinatorial Libraries

Description

The Developmental Therapeutics Program of NCI operates an anti-cancer screening program for the benefit of the extramural research community. The program, which is operated at no cost to suppliers, accepts both natural and synthetic compounds from scientists in the academic and industrial communities worldwide. Entrance into this program is through a supplier-driven on-line submission form. For screening of natural product extracts, the Natural Products Branch should be contacted. For submission of compounds on a confidential basis, a Confidential Screening Agreement is available from the: Drug Synthesis & Chemistry Branch Phone: 301-496-8795 Fax: 301-480-4817. The acquisition of combinatorial libraries for high throughput screening is coordinated by the Access and Information Group.

NCI Division, Office, Center (DOC)

Division of Cancer Treatment and Diagnosis (DCTD)

Category(s)

Research and Manufacturing Services
Anti-Cancer Drug Screening Program

Contact(s)

White, Stephen 
+1 301 496 5307 

Web Sites

Drug Synthesis & Chemistry Branch
Natural Products Branch

Availability

CD

National Cancer Institute U.S. Department of Health & Human Services National Institutes of Health USA.gov